136 related articles for article (PubMed ID: 23970383)
1. Evaluating the roles of autophagy and lysosomal trafficking defects in intracellular distribution-based drug-drug interactions involving lysosomes.
Logan R; Kong A; Krise JP
J Pharm Sci; 2013 Nov; 102(11):4173-80. PubMed ID: 23970383
[TBL] [Abstract][Full Text] [Related]
2. Amine-containing molecules and the induction of an expanded lysosomal volume phenotype: a structure-activity relationship study.
Logan R; Kong AC; Axcell E; Krise JP
J Pharm Sci; 2014 May; 103(5):1572-80. PubMed ID: 24647827
[TBL] [Abstract][Full Text] [Related]
3. Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction.
Funk RS; Krise JP
Mol Pharm; 2012 May; 9(5):1384-95. PubMed ID: 22449202
[TBL] [Abstract][Full Text] [Related]
4. Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications.
Logan R; Funk RS; Axcell E; Krise JP
Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):943-58. PubMed ID: 22616667
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent effects of hydrophobic amine-containing drugs on lysosome structure and biogenesis in cultured human fibroblasts.
Logan R; Kong AC; Krise JP
J Pharm Sci; 2014 Oct; 103(10):3287-96. PubMed ID: 25042198
[TBL] [Abstract][Full Text] [Related]
6. Interactions between promazine and antidepressants at the level of cellular distribution.
Daniel WA; Wójcikowski J
Pharmacol Toxicol; 1997 Dec; 81(6):259-64. PubMed ID: 9444666
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of Lysosomal Trapping of Basic Lipophilic Compounds Using In Vitro Assays and In Silico Predictions Based on the Determination of the Full pH Profile of the Endo-/Lysosomal System in Rat Hepatocytes.
Schmitt MV; Lienau P; Fricker G; Reichel A
Drug Metab Dispos; 2019 Jan; 47(1):49-57. PubMed ID: 30409837
[TBL] [Abstract][Full Text] [Related]
8. Lysosomotropic Drugs: Pharmacological Tools to Study Lysosomal Function.
Pisonero-Vaquero S; Medina DL
Curr Drug Metab; 2017; 18(12):1147-1158. PubMed ID: 28952432
[TBL] [Abstract][Full Text] [Related]
9. The Lysosomotropic Activity of Hydrophobic Weak Base Drugs is Mediated via Their Intercalation into the Lysosomal Membrane.
Stark M; Silva TFD; Levin G; Machuqueiro M; Assaraf YG
Cells; 2020 Apr; 9(5):. PubMed ID: 32349204
[TBL] [Abstract][Full Text] [Related]
10. Lysosomes as mediators of drug resistance in cancer.
Zhitomirsky B; Assaraf YG
Drug Resist Updat; 2016 Jan; 24():23-33. PubMed ID: 26830313
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of cellular distribution of psychotropic drugs. Significance for drug action and interactions.
Daniel WA
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):65-73. PubMed ID: 12551728
[TBL] [Abstract][Full Text] [Related]
12. In Vitro and in Silico Tools To Assess Extent of Cellular Uptake and Lysosomal Sequestration of Respiratory Drugs in Human Alveolar Macrophages.
Ufuk A; Assmus F; Francis L; Plumb J; Damian V; Gertz M; Houston JB; Galetin A
Mol Pharm; 2017 Apr; 14(4):1033-1046. PubMed ID: 28252969
[TBL] [Abstract][Full Text] [Related]
13. Lipophilic cationic drugs increase the permeability of lysosomal membranes in a cell culture system.
Kornhuber J; Henkel AW; Groemer TW; Städtler S; Welzel O; Tripal P; Rotter A; Bleich S; Trapp S
J Cell Physiol; 2010 Jul; 224(1):152-64. PubMed ID: 20301195
[TBL] [Abstract][Full Text] [Related]
14. Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications.
Kaufmann AM; Krise JP
J Pharm Sci; 2007 Apr; 96(4):729-46. PubMed ID: 17117426
[TBL] [Abstract][Full Text] [Related]
15. A review of drug-induced lysosomal disorders of the liver in man and laboratory animals.
Schneider P; Korolenko TA; Busch U
Microsc Res Tech; 1997 Feb; 36(4):253-75. PubMed ID: 9140926
[TBL] [Abstract][Full Text] [Related]
16. Lysosomal Biogenesis and Implications for Hydroxychloroquine Disposition.
Collins KP; Witta S; Coy JW; Pang Y; Gustafson DL
J Pharmacol Exp Ther; 2021 Feb; 376(2):294-305. PubMed ID: 33172973
[TBL] [Abstract][Full Text] [Related]
17. Lysosomal adaptation: How cells respond to lysosomotropic compounds.
Lu S; Sung T; Lin N; Abraham RT; Jessen BA
PLoS One; 2017; 12(3):e0173771. PubMed ID: 28301521
[TBL] [Abstract][Full Text] [Related]
18. Incorporation of lysosomal sequestration in the mechanistic model for prediction of tissue distribution of basic drugs.
Assmus F; Houston JB; Galetin A
Eur J Pharm Sci; 2017 Nov; 109():419-430. PubMed ID: 28823852
[TBL] [Abstract][Full Text] [Related]
19. Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells).
Kazmi F; Hensley T; Pope C; Funk RS; Loewen GJ; Buckley DB; Parkinson A
Drug Metab Dispos; 2013 Apr; 41(4):897-905. PubMed ID: 23378628
[TBL] [Abstract][Full Text] [Related]
20. Identification of lysosomotropic compounds based on the distribution and size of lysosomes.
Seo I; Jha BK; Lim JG; Suh SI; Suh MH; Baek WK
Biochem Biophys Res Commun; 2014 Jul; 450(1):189-94. PubMed ID: 24878535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
